Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Evaluation of pulmonary TB treatment efficiency depending on polymorphism of glutathione-S-transferasexenobiotic biotransformation enzyme and on sensitivity profile

Tetiana Sprynsian, Lilia Todoriko, Igor Semianiv
European Respiratory Journal 2016 48: PA2726; DOI: 10.1183/13993003.congress-2016.PA2726
Tetiana Sprynsian
1TB, Communicable Diseases Intensive Care Association (INCURE), Kiev, Ukraine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lilia Todoriko
2TB, Bukovina State Medical University, Chernivtsy, Ukraine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Igor Semianiv
2TB, Bukovina State Medical University, Chernivtsy, Ukraine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Objective: To evaluate tuberculosis treatment efficiency depending on the combination of isoforms of allelic variants of genes GSTM1 and GSTT1 and on the resistance profile.

Methods: We have examined 100 patients with newly diagnosed TB (NDTB) and with multidrug-resistant TB (MDR-TB). Polymorphism GSTM1 areas were isolated using complex multi PCR for M. Arana et all (1996).

Results: Patients with sensitive pulmonary NDTB who are carriers of the wild alleles (GSTM1 + / GSTT1 +) experienced the bacterioexcretion termination more frequently with the 60thdose (by18,40%; (χ² = 3,59, p = 0,052)); in MDR-TB the negative sputum microscopy was recorded more frequently with the 120/240th doses (by 45.64% (p=0.002)), respectively. With null genotype in haplotypes, the frequency of bacterioexcretionat a dose of 60 was lower by 47,23% (χ² = 18,67, p < 0.001) with a high probability of the forecast for ineffective treatment of sensitive NDTB, while in MRD-TB the bacterioexcretion stopped in 66.67% of people more frequently with higher doses of drugs (240).

Conclusions: The deletion in the promotive area of both genes (GSTT10 / 0 / GSTM10 / 0) increases the risk of no effect of antituberculosis therapy resulting from the cessation of bacterioexcretion by 16.67 times [OR = 24,50, 95% CI OR: 2,18-142 64, p = 0.009]. The presence of mutant isoform GSTM1 genotype in haplotype (GSTT1 + / GSTM10 / 0) reduces the chances of effective treatment, which is the lowest with the 60th dose inNDTBand the 240th dose in MDR-TB [OR=0,07, 95%CIOR: 0,09-0,57, p=0,002 andOR=0,37, 95%CIOR: 0,14-0,97, p=0,04].

  • Tuberculosis - diagnosis
  • Tuberculosis - management
  • Tuberculosis - mechanism
  • Copyright ©the authors 2016
Previous
Back to top
Vol 48 Issue suppl 60 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of pulmonary TB treatment efficiency depending on polymorphism of glutathione-S-transferasexenobiotic biotransformation enzyme and on sensitivity profile
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Evaluation of pulmonary TB treatment efficiency depending on polymorphism of glutathione-S-transferasexenobiotic biotransformation enzyme and on sensitivity profile
Tetiana Sprynsian, Lilia Todoriko, Igor Semianiv
European Respiratory Journal Sep 2016, 48 (suppl 60) PA2726; DOI: 10.1183/13993003.congress-2016.PA2726

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Evaluation of pulmonary TB treatment efficiency depending on polymorphism of glutathione-S-transferasexenobiotic biotransformation enzyme and on sensitivity profile
Tetiana Sprynsian, Lilia Todoriko, Igor Semianiv
European Respiratory Journal Sep 2016, 48 (suppl 60) PA2726; DOI: 10.1183/13993003.congress-2016.PA2726
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Does every necrotizing granulomatous inflammation at NSCLC resection materials require treatment?
  • Effect of treatment of drug resistant tuberculosis on thyroid stimulating hormone
Show more 10.2 Tuberculosis

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society